P
Peter Goldstraw
Researcher at National Institutes of Health
Publications - 231
Citations - 28207
Peter Goldstraw is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Lung cancer & Lung cancer staging. The author has an hindex of 68, co-authored 231 publications receiving 25178 citations. Previous affiliations of Peter Goldstraw include Harefield Hospital & National Health Service.
Papers
More filters
Journal ArticleDOI
The long-term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions.
TL;DR: Pleuroperitoneal shunt insertion provides effective and safe palliation for malignant pleural effusion when associated with the 'trapped lung syndrome', there are however complications which require revision or shunt removal.
Journal ArticleDOI
The IASLC Lung Cancer Staging Project Data Elements for the Prospective Project
Dorothy J. Giroux,Ramón Rami-Porta,Kari Chansky,John Crowley,Patti A. Groome,Pieter E. Postmus,Valerie W. Rusch,Jean-Paul Sculier,Frances A. Shepherd,Leslie H. Sobin,Peter Goldstraw +10 more
TL;DR: The International Staging Committee of the International Association for the Study of Lung Cancer now issues this call for participation in the Prospective Project designed to assess the validity of each component of T, N, and M, and other factors relevant to lung cancer staging and prognosis.
Journal ArticleDOI
Mucinous cells in type 1 pulmonary congenital cystic adenomatoid malformation as mucinous bronchioloalveolar carcinoma precursors.
Sylvie Lantuejoul,Andrew G. Nicholson,Giuliana Sartori,Christian Piolat,Claire Danel,Eva Brabencova,Peter Goldstraw,Elisabeth Brambilla,Giulio Rossi +8 more
TL;DR: Type 1 CCAM mucinous cells share the same differentiation profile with corresponding mucinous BAC, consistent with a common bronchial origin, and justifies their consideration as BAC precursors.
Journal ArticleDOI
The ITMIG/IASLC thymic epithelial tumors staging project: A proposed lymph node map for thymic epithelial tumors in the forthcoming 8th edition of the TNM classification of malignant tumors
F.Y. Bhora,David J. Chen,Frank C. Detterbeck,Hisao Asamura,Conrad Falkson,Pier Luigi Filosso,Giuseppe Giaccone,James Huang,Jhingook Kim,Kazuya Kondo,Marco Lucchi,Mirella Marino,Edith M. Marom,Andrew G. Nicholson,Meinoshin Okumura,Enrico Ruffini,Paul Van Schil,Peter Goldstraw,Ramón Rami-Porta,David Ball,David G. Beer,Ricardo Beyruti,Vanessa Bolejack,Kari Chansky,John Crowley,Wilfried Eberhardt,John G. Edwards,Françoise Galateau-Salle,Dorothy Giroux,Fergus V. Gleeson,Patti A. Groome,Catherine Kennedy,Young Tae Kim,Laura Kingsbury,Haruhiko Kondo,Mark Krasnik,Kaoru Kubota,Antoon Lerut,Gustavo Lyons,Jan P. van Meerbeeck,Alan Mitchell,Takashi Nakano,Anna K. Nowak,Michael D Peake,Thomas W. Rice,Kenneth E. Rosenzweig,Valerie W. Rusch,Nagahiro Saijo,Jean-Paul Sculier,Lynn Shemanski,Kelly G. Stratton,Kenji Suzuki,Yuji Tachimori,Charles F. Thomas,William D. Travis,Ming-Sound Tsao,Andrew T. Turrisi,Johan Vansteenkiste,Hirokazu Watanabe,Yi-Long Wu,Paul Baas,Jeremy J. Erasmus,Seiki Hasegawa,Kouki Inai,Kemp H. Kernstine,Hedy L. Kindler,Lee M. Krug,Kristiaan Nackaerts,Harvey I. Pass,David C. Rice,Eugene H. Blackstone +70 more
TL;DR: An empiric node map is proposed here to establish a universal language for reporting as well as characterize the staging of this disease more accurately and to define node staging as part of a universal stage classification for thymic malignancy.
Journal ArticleDOI
Assessment of Cell Line Models of Primary Human Cells by Raman Spectral Phenotyping
TL;DR: This study used Raman microspectroscopy to characterize live A549 cells from a unique molecular biochemical perspective to shed light on their suitability as a model for primary human pulmonary alveolar type II (ATII) cells and found that A549 spectra are statistically more similar to ATI spectra than to ATII spectra.